Morningstar Fund Report
Centuria Healthcare Direct Medical No.1
Fund Report | Report generated 29 May 2022 | 
Performance
30 Apr 2022
Growth of $10,000
Fund: Centuria Healthcare Direct Medical No.1
Index: S&P/ASX 200 A-REIT TR
Category: Unlisted and Direct Property
Financial Year Total Returns
| Jun-19 | Jun-20 | Jun-21 | Apr-22 | |
|---|---|---|---|---|
| Fund | 7.49 | 7.62 | 13.67 | 16.93 |
| +/- Cat | 0.44 | -3.63 | 2.81 | 5.39 |
| +/- Index | -11.84 | 28.95 | -19.57 | 9.72 |
Trailing Total Returns
as at 30 Apr 2022| Total Return | +/- Cat | +/- Index | Cat Rank | |
|---|---|---|---|---|
| 1 Month | 1.18 | 0.63 | 0.60 | -- |
| 3 Month | 1.28 | -0.20 | -1.99 | -- |
| 1 Year | 19.72 | 1.81 | 4.66 | -- |
| 3 Year | 13.53 | 0.47 | 7.27 | -- |
| 5 Year | 10.20 | -0.33 | 2.83 | -- |
Risk Analysis
as at 30 Apr 2022| 3-Year Risk Measures | Fund | Category | Index |
|---|---|---|---|
| Standard Deviation | -- | 8.5 | 26.9 |
| Sharpe Ratio | -- | 1.6 | 0.37 |
| R-Squared | -- | 19.45 | -- |
| Beta | -- | 0.13 | -- |
| Alpha | -- | 10.53 | -- |
Fund Details
| Fund Inception | 25 Nov 2014 |
| Responsible Entity | Heathley Asset Management Limited |
| Fund Manager | Heathley Asset Management Limited |
| Base Currency | $A |
| Net Assets $Mil (as at 28 Feb 2021) |
75.84 |
| Minimum Investment $ | 25,000 |
| Regular Savings Plan (Yes/No) |
-- |
| Cash Distributions | Quarterly |
Current Investment Style
Style Box is unavailable.
Asset Allocation
% as at 31 Mar 2021
| Domestic Equity | 0.000 |
| International Equity | 0.000 |
| Listed Property | 0.000 |
| Unlisted Property | 100.000 |
| Domestic Fixed Interest | 0.000 |
| International Fixed Interest | 0.000 |
| Cash | 0.000 |
| Other | 0.000 |
Morningstar Sustainability Rating 
Learn more
Quick Stats
as at 30 Apr 2022
| APIR Code | HTH0015AU |
| Legal Type | Investment Trusts |
| Status | Closed |
| Category | Unlisted and Direct Property |
| Entry Price $ | -- |
| Exit Price $ | 0.8798 |
| Exit Price 1 Week Change $ |
-- |
Morningstar Ratings
| Overall |
|
| 3 Year | |
| 5 Year | |
| 10 Year |
Prosective Fees & Costs
as at 24 Feb 2017
| Total Cost Ratio (Prospective) | 1.47% |
| Investment Management Fee | 1.20% |
| Performance Fee Costs | -- |
| Administration Fees & Costs | -- |
| Buy Spread/Sell Spread | 0.00% / 0.00% |